Gum disease breakthrough? own blood gel may boost healing
NCT ID NCT07363135
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a gel made from patients' own blood, called albumin platelet-rich fibrin (Alb-PRF), can improve gum healing after deep cleaning for advanced gum disease. Twenty-three adults with Stage 3 periodontitis received the gel in deep gum pockets on one side of the mouth, while the other side got standard cleaning alone. Researchers measured gum pocket depth, attachment levels, and growth factors over 6 months to see if the gel leads to better tissue repair.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- albumin platelet-rich fibrin (Alb-PRF) gel
- What this could lead to
- If it works, this could lead to a better way to heal gums and bone after deep cleaning, reducing tooth loss from advanced gum disease.
- What could go wrong
- This is a small, early study with only 23 people, so results may not apply to everyone. The gel is experimental and may not improve healing over standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
23 people
The number who actually took part.
- Started
-
Nov 2024
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Being diagnosed with Stage 3 Grade B periodontitis * Being between the ages of 18-65 * Vertical bone defects in two quadrants Exclusion Criteria: * Smoking * Having a systemic disease * Taking any medication * Being pregnant or breastfeeding * Having received chemotherapy, radiotherapy or immunosuppressant treatments * Having received periodontal treatment in the last 6 months•Having used antibiotics in the last 6 months
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Periodontitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gulhane Faculty of Dentistry, University of Health Sciences, Ankara, Turkey
Ankara, Keçiören, 06010, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday supplements boost gum disease therapy?
- Can pulling a loose tooth and putting it back save it?
- Gum fluid proteins eyed as link between smoking and periodontitis
- Gum fluid holds clues to Behçet's disease puzzle
- Magnifying the fight against gum disease: loupe vs microscope
- Can teaching people with diabetes to care for their gums also help their blood sugar?